These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmacogenomics of lung cancer: with a view to address EGFR-targeted therapies. Joshi VA; Kucherlapati R Pharmacogenomics; 2007 Sep; 8(9):1211-20. PubMed ID: 17924836 [TBL] [Abstract][Full Text] [Related]
9. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors. John T; Liu G; Tsao MS Oncogene; 2009 Aug; 28 Suppl 1():S14-23. PubMed ID: 19680292 [TBL] [Abstract][Full Text] [Related]
10. Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies. Stella GM; Luisetti M; Inghilleri S; Cemmi F; Scabini R; Zorzetto M; Pozzi E Respir Med; 2012 Feb; 106(2):173-83. PubMed ID: 22104541 [TBL] [Abstract][Full Text] [Related]
11. The role of EGFR inhibition in the treatment of non-small cell lung cancer. Ray M; Salgia R; Vokes EE Oncologist; 2009 Nov; 14(11):1116-30. PubMed ID: 19892771 [TBL] [Abstract][Full Text] [Related]
12. The role of genetic testing in the prediction of response to EGFR inhibitors in NSCLC. Hirsch FR Oncogene; 2009 Aug; 28 Suppl 1():S1-3. PubMed ID: 19680291 [TBL] [Abstract][Full Text] [Related]
13. Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer. Kotsakis A; Georgoulias V Expert Opin Pharmacother; 2010 Oct; 11(14):2363-89. PubMed ID: 20586711 [TBL] [Abstract][Full Text] [Related]
14. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer. Langer C; Soria JC Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973 [TBL] [Abstract][Full Text] [Related]
16. The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC. Gately K; O'Flaherty J; Cappuzzo F; Pirker R; Kerr K; O'Byrne K J Clin Pathol; 2012 Jan; 65(1):1-7. PubMed ID: 22039281 [TBL] [Abstract][Full Text] [Related]
17. Targeting resistance in lung cancer. Cancer Discov; 2013 Dec; 3(12):OF9. PubMed ID: 24327718 [No Abstract] [Full Text] [Related]